Danirixin blocks agonist-induced neutrophil CD11b expression in vitro (IC50 = 420/890 nM against induction by 10 nM human CXCL1/rat CXCL2 using rat/human whole blood) and prevents lung neutrophils influx in rats in vivo following aerosol lipopolysaccharide or ozone challenge (ED50 = 1
Immunohistochemical analysis of paraffin-embedded Human liver cancer tissue or WDR18 antigen-treated (Neutralization experiment) using P105520(WDR18 Antibody) at dilution 1/25
Dec 2010] Swissprot No O60716 Gene Accession 1500 WB Predicted band size 108 kDa WB Positive control WB Recommended dilution 500-2000 IHC predicted cell location Predicted cell location: Cytoplasm and Cell membrane IHC positive control Positive control: Human colon cancer IHC Recommed dilution Recommended dilution: 50-100 Storage
The genes encoding the type II cytokeratins are clustered in a region of chromosome 12q12-q13
fatty liver disease
ACES 99% Biochemical Grade Package Size:5000g Danirixin blocks agonist-induced neutrophil CD11bSynonym(s): 2 [(2 Amino 2 oxoethyl)azaniumyl]ethanesulfonate, 2 [(Carbamoylmethyl)amino]ethane 1 sulfonic acid, N (2 Acetamido) 2 aminoethanesulfonic acid, N (Carbamoylmethyl) 2 aminoethanesulfonic acid, N (Carbamoylmethyl)taurine Description In biological experiments, it is an important pH stabilizing reagent. Typically, an appropriate weak acid is mixed with its conjugate base to achieve a suitable pH value. Most biological reactions occur under